Seeing the forest and the trees: using network analysis to develop an organizational blueprint of state tobacco control systems

Social Science & Medicine
Jenine K HarrisNancy B Mueller

Abstract

In the United States, tobacco control activities are organized primarily in state tobacco control programs. These programs are comprised of public and private agencies working together to reduce tobacco use. The human, financial, and informational resources that go into state tobacco control programs are documented, and the outcomes of these programs have been studied in terms of health and health behavior. However, little is known about the organizational infrastructure that transforms the human, financial, and informational resources into positive health outcomes. This study examined the inter-organizational relationships among key partner agencies in eight state tobacco control programs. The state programs varied in terms of funding level, funding stability, and region of the country. Using a network analytic approach we asked an average of 14 agencies in each state program about their contacts and partnerships with the other key tobacco control agencies in their state program. Using network visualization and statistics we determined that the state networks shared some common features such as a highly central lead agency, but also had differences in network structure in terms of density and centralization. Using blockmodelin...Continue Reading

References

Sep 21, 2001·Journal of Urban Health : Bulletin of the New York Academy of Medicine·J KwaitD D Celentano
Aug 30, 2003·Journal of Health Economics·Matthew C FarrellyFrank J Chaloupka
Jan 27, 2005·American Journal of Public Health·John A TaurasTerry F Pechacek
Dec 27, 2005·Journal of Health Organization and Management·Keith G ProvanJill Guernsey de Zapien
Feb 2, 2006·American Journal of Public Health·Scott J Leischow, Bobby Milstein
Mar 15, 2006·American Journal of Preventive Medicine·Ronda C Zakocs, Erika M Edwards
Sep 19, 2006·American Journal of Preventive Medicine·Nancy B MuellerTanya P Montgomery
Dec 2, 2006·American Journal of Public Health·Alison Snow JonesDavid G Altman
Jan 16, 2007·Annual Review of Public Health·Douglas A Luke, Jenine K Harris
Mar 3, 2007·American Journal of Public Health·Thomas W ValenteMary Ann Pentz

❮ Previous
Next ❯

Citations

Dec 18, 2013·American Journal of Public Health·Rebecca LobbAisha K Lofters
Jan 10, 2012·Annual Review of Public Health·Douglas A Luke, Katherine A Stamatakis
May 15, 2010·American Journal of Public Health·Douglas A LukeNancy B Mueller
Aug 7, 2010·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Scott J LeischowPamela I Clark
May 14, 2011·American Journal of Public Health·Jenine K HarrisAimee I James
Feb 5, 2013·Implementation Science : IS·Sarah F SchellAlicia C Bunger
Mar 3, 2010·Annual Review of Public Health·Timothy W Van WavePeggy A Honoré
Sep 22, 2012·American Journal of Public Health·Scott J LeischowJessie Saul
Sep 16, 2015·International Journal of Environmental Research and Public Health·Sarah Moreland-Russell, Bobbi J Carothers
Jan 16, 2016·Evaluation and Program Planning·Amy M SalazarRichard F Catalano
Oct 17, 2012·Research in Social & Administrative Pharmacy : RSAP·Andrea L KjosJon C Schommer
Mar 9, 2010·Social Science & Medicine·H McAneneyF Kee
Aug 21, 2015·Preventing Chronic Disease·Miruna Petrescu-PrahovaLynda A Anderson
Dec 3, 2014·Social Science & Medicine·Martin W SchoenBobbi J Carothers
Jul 18, 2015·International Journal of Social Research Methodology·Heide WeishaarJeff Collin
Oct 23, 2013·Health Education & Behavior : the Official Publication of the Society for Public Health Education·Douglas A LukeJenine K Harris
Apr 21, 2017·Public Health Reports·Jenine K HarrisPatrick Fowler
Aug 11, 2015·International Journal of Environmental Research and Public Health·Jonathon P LeiderShelley Hearne
Mar 17, 2010·Expert Opinion on Biological Therapy·Roy Fleischmann
Jul 25, 2017·Addiction·Yorghos ApostolopoulosKristen Hassmiller Lich
Feb 26, 2016·Journal of Public Health Management and Practice : JPHMP·Jenine K HarrisShelley Hearne
Jun 9, 2020·Public Health Reports·Danielle A Rankin, Sarah D Matthews
Feb 16, 2013·Journal of Public Health Management and Practice : JPHMP·René LavinghouzeJudith Ottoson
May 1, 2019·Traffic Injury Prevention·Rebecca B NaumannStephen W Marshall
Apr 10, 2017·BMC Public Health·Katherine CullertonDanielle Gallegos
Jul 25, 2021·International Journal of Environmental Research and Public Health·Irina TimmHagen Wäsche

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.